Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model

Introduction: Thalassemia is a hereditary anemia usually treated with regular blood transfusions, which can result in elevated levels of total iron in the body. As soon as the capacity of iron-regulating proteins (e.g., ferritin, transferrin) are used up, free plasma iron increases generating reacti...

Full description

Bibliographic Details
Main Authors: Ari Estuningtyas, Tri Wahyuni, Pustika Amalia Wahidiyat, Ernie H Poerwaningsih, Hans-Joachim Freisleben
Format: Article
Language:English
Published: Nikan Research Institute 2019-01-01
Series:Journal of HerbMed Pharmacology
Subjects:
Online Access:http://herbmedpharmacol.com/PDF/jhp-7349
id doaj-9e93ab0fa46f464990c1f31e483c2da7
record_format Article
spelling doaj-9e93ab0fa46f464990c1f31e483c2da72021-08-02T16:41:50ZengNikan Research InstituteJournal of HerbMed Pharmacology2345-50042019-01-0181212710.15171/jhp.2019.04jhp-7349Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat modelAri Estuningtyas0Tri Wahyuni1Pustika Amalia Wahidiyat2Ernie H Poerwaningsih3Hans-Joachim Freisleben4Department of Pharmacology, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaPharmacology Division, Faculty of Pharmaceutical, Universitas Indonesia, Depok, IndonesiaDepartment of Pediatrics, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Pharmacy, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaMedical Research Unit, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaIntroduction: Thalassemia is a hereditary anemia usually treated with regular blood transfusions, which can result in elevated levels of total iron in the body. As soon as the capacity of iron-regulating proteins (e.g., ferritin, transferrin) are used up, free plasma iron increases generating reactive oxygen species (ROS), leading to oxidative stress. Hence, blood transfusions should be accompanied by iron-chelating therapy, e.g., deferiprone (DFP). The purpose of this study was to evaluate the effect of mangiferin (M) and an aqueous leaf extract of Mangifera foetida L (EMF) as alternative iron-chelating antioxidants in an animal model. Methods: Thirty male Sprague Dawley rats were randomly divided into 5 equal groups: normal control, iron overload (IO), IO+DFP, IO+M, and IO+EMF. Iron overload was induced by intraperitoneal iron dextran injection with a total dose of 90 mg/mouse (15 mg Fe/mouse every 3-4 days for 3 weeks) followed by oral administration of DFP 462.5 mg/kg, mangiferin 75 mg/kg, or EMF 2.930 g/kg for 7 days. Results: Body weight (BW) increased in all groups during the 4 weeks of experiment, except for the IO group. As expected, DFP decreased significantly the total plasma iron and increased iron excretion via urine in iron-overloaded rats (positive control), mangiferin and EMF had similar – although slightly smaller – effects than DFP. The antioxidant activity of M and EMF were stronger compared to DFP as determined by plasma superoxide dismutase (SOD) activity. Conclusion: Mangiferin and EMF have iron-chelating and antioxidant effects and might be used for the treatment of iron overload in the body.http://herbmedpharmacol.com/PDF/jhp-7349ThalassemiaMangiferinMangifera foetidaMedicinal plantIron overloadIron chelationIron excretion
collection DOAJ
language English
format Article
sources DOAJ
author Ari Estuningtyas
Tri Wahyuni
Pustika Amalia Wahidiyat
Ernie H Poerwaningsih
Hans-Joachim Freisleben
spellingShingle Ari Estuningtyas
Tri Wahyuni
Pustika Amalia Wahidiyat
Ernie H Poerwaningsih
Hans-Joachim Freisleben
Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
Journal of HerbMed Pharmacology
Thalassemia
Mangiferin
Mangifera foetida
Medicinal plant
Iron overload
Iron chelation
Iron excretion
author_facet Ari Estuningtyas
Tri Wahyuni
Pustika Amalia Wahidiyat
Ernie H Poerwaningsih
Hans-Joachim Freisleben
author_sort Ari Estuningtyas
title Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
title_short Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
title_full Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
title_fullStr Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
title_full_unstemmed Mangiferin and mangiferin-containing leaf extract from Mangifera foetida L for therapeutic attenuation of experimentally induced iron overload in a rat model
title_sort mangiferin and mangiferin-containing leaf extract from mangifera foetida l for therapeutic attenuation of experimentally induced iron overload in a rat model
publisher Nikan Research Institute
series Journal of HerbMed Pharmacology
issn 2345-5004
publishDate 2019-01-01
description Introduction: Thalassemia is a hereditary anemia usually treated with regular blood transfusions, which can result in elevated levels of total iron in the body. As soon as the capacity of iron-regulating proteins (e.g., ferritin, transferrin) are used up, free plasma iron increases generating reactive oxygen species (ROS), leading to oxidative stress. Hence, blood transfusions should be accompanied by iron-chelating therapy, e.g., deferiprone (DFP). The purpose of this study was to evaluate the effect of mangiferin (M) and an aqueous leaf extract of Mangifera foetida L (EMF) as alternative iron-chelating antioxidants in an animal model. Methods: Thirty male Sprague Dawley rats were randomly divided into 5 equal groups: normal control, iron overload (IO), IO+DFP, IO+M, and IO+EMF. Iron overload was induced by intraperitoneal iron dextran injection with a total dose of 90 mg/mouse (15 mg Fe/mouse every 3-4 days for 3 weeks) followed by oral administration of DFP 462.5 mg/kg, mangiferin 75 mg/kg, or EMF 2.930 g/kg for 7 days. Results: Body weight (BW) increased in all groups during the 4 weeks of experiment, except for the IO group. As expected, DFP decreased significantly the total plasma iron and increased iron excretion via urine in iron-overloaded rats (positive control), mangiferin and EMF had similar – although slightly smaller – effects than DFP. The antioxidant activity of M and EMF were stronger compared to DFP as determined by plasma superoxide dismutase (SOD) activity. Conclusion: Mangiferin and EMF have iron-chelating and antioxidant effects and might be used for the treatment of iron overload in the body.
topic Thalassemia
Mangiferin
Mangifera foetida
Medicinal plant
Iron overload
Iron chelation
Iron excretion
url http://herbmedpharmacol.com/PDF/jhp-7349
work_keys_str_mv AT ariestuningtyas mangiferinandmangiferincontainingleafextractfrommangiferafoetidalfortherapeuticattenuationofexperimentallyinducedironoverloadinaratmodel
AT triwahyuni mangiferinandmangiferincontainingleafextractfrommangiferafoetidalfortherapeuticattenuationofexperimentallyinducedironoverloadinaratmodel
AT pustikaamaliawahidiyat mangiferinandmangiferincontainingleafextractfrommangiferafoetidalfortherapeuticattenuationofexperimentallyinducedironoverloadinaratmodel
AT erniehpoerwaningsih mangiferinandmangiferincontainingleafextractfrommangiferafoetidalfortherapeuticattenuationofexperimentallyinducedironoverloadinaratmodel
AT hansjoachimfreisleben mangiferinandmangiferincontainingleafextractfrommangiferafoetidalfortherapeuticattenuationofexperimentallyinducedironoverloadinaratmodel
_version_ 1721229516574031872